Hodgkin Disease

Displaying 1 - 6 of 6CSV
Kahn, J. M., Mauz-Korholz, C., Hernandez, T., Milgrom, S. A., & Castellino, S. M. (2024). Pediatric and Adolescent Hodgkin Lymphoma: Paving the Way for Standards of Care and Shared Decision Making. American Society of Clinical Oncology Educational Book, 44(3). https://doi.org/10.1200/edbk_432420
Publication Date
Mellgard, G., Stoffel, E., Michel, A., Iqbal, F., Provenzano, A., Akpan, I. J., Amengual, J., & Pro, B. (2023). Hypereosinophilic syndrome with leptomeningeal involvement: a not-so-classical case report of classical Hodgkin Lymphoma. Leukemia & Lymphoma, 64(13), 2208–2213. https://doi.org/10.1080/10428194.2023.2252124
Publication Date
Castellino, S. M., Giulino‐Roth, L., Harker‐Murray, P., Kahn, J. M., Forlenza, C., Cho, S., Hoppe, B., Parsons, S. K., & Kelly, K. M. (2023). Children’s Oncology Group’s 2023 blueprint for research: Hodgkin lymphoma. Pediatric Blood & Cancer, 70(S6). Portico. https://doi.org/10.1002/pbc.30580
Publication Date
Allen, P. B., Lu, X., Chen, Q., O’Shea, K., Chmiel, J. S., Slonim, L. B., Sukhanova, M., Savas, H., Evens, A. M., Advani, R., Pro, B., Karmali, R., Palmer, B., Bayer, R. A., Eisner, R. M., Mou, E., Dillehay, G., Gordon, L. I., & Winter, J. N. (2023). Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma. Blood Advances, 7(12), 2670–2676. https://doi.org/10.1182/bloodadvances.2022008116
Publication Date
Manson, G., Lemchukwu, A. C., Mokrane, F.-Z., Lopci, E., Aide, N., Vercellino, L., Houot, R., & Dercle, L. (2022). Interpretation of 2-[18F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors. European Radiology, 32(9), 6536–6544. https://doi.org/10.1007/s00330-022-08669-8
Publication Date
Kahn, J. M., Pei, Q., Friedman, D. L., Kaplan, J., Keller, F. G., Hodgson, D., Wu, Y., Appel, B. E., Bhatia, S., Henderson, T. O., Schwartz, C. L., Kelly, K. M., & Castellino, S. M. (2022). Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children’s oncology group trials. The Lancet Haematology, 9(1), e49–e57. https://doi.org/10.1016/s2352-3026(21)00349-5
Publication Date